Qiagen N.V. (QGEN)

USD 43.13

(2.2%)

Total Debt Summary of Qiagen N.V.

  • Qiagen N.V.'s latest annual total debt in 2023 was 1.61 Billion USD , down -13.45% from previous year.
  • Qiagen N.V.'s latest quarterly total debt in 2024 Q2 was 1.4 Billion USD , down -6.77% from previous quarter.
  • Qiagen N.V. reported annual total debt of 1.86 Billion USD in 2022, down -4.14% from previous year.
  • Qiagen N.V. reported annual total debt of 1.94 Billion USD in 2021, down -4.19% from previous year.
  • Qiagen N.V. reported quarterly total debt of 1.4 Billion USD for 2024 Q2, down -6.77% from previous quarter.
  • Qiagen N.V. reported quarterly total debt of 1.61 Billion USD for 2023 FY, down -13.45% from previous quarter.

Annual Total Debt Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Total Debt of Qiagen N.V. (2023 - 1995)

Year Total Debt Total Debt Growth
2023 1.61 Billion USD -13.45%
2022 1.86 Billion USD -4.14%
2021 1.94 Billion USD -4.19%
2020 2.02 Billion USD 18.78%
2019 1.7 Billion USD -21.52%
2018 2.17 Billion USD 23.66%
2017 1.75 Billion USD 64.77%
2016 1.06 Billion USD 0.71%
2015 1.05 Billion USD -9.6%
2014 1.17 Billion USD 38.63%
2013 845.48 Million USD -0.18%
2012 846.99 Million USD 43.57%
2011 589.95 Million USD -32.42%
2010 873 Million USD -8.2%
2009 950.97 Million USD -2.73%
2008 977.7 Million USD -0.82%
2007 985.79 Million USD 93.66%
2006 509.02 Million USD 143.01%
2005 209.46 Million USD -4.39%
2004 219.09 Million USD 77.56%
2003 123.38 Million USD 12.06%
2002 110.11 Million USD 22.72%
2001 89.72 Million USD 195.72%
2000 30.34 Million USD -9.07%
1999 33.36 Million USD 131.71%
1998 14.4 Million USD 39.81%
1997 10.3 Million USD 15.73%
1996 8.9 Million USD 15.58%
1995 7.7 Million USD 0.0%

Peer Total Debt Comparison of Qiagen N.V.

Name Total Debt Total Debt Difference
Agilent Technologies, Inc. 2.73 Billion USD 41.092%
Charles River Laboratories International, Inc. 3.06 Billion USD 47.458%
Quest Diagnostics Incorporated 5.36 Billion USD 69.992%
Danaher Corporation 19.53 Billion USD 91.753%
Enzo Biochem, Inc. 265 Thousand USD -607871.698%
IQVIA Holdings Inc. 14.23 Billion USD 88.679%
Laboratory Corporation of America Holdings 5.95 Billion USD 72.941%
Mettler-Toledo International Inc. 2.08 Billion USD 22.573%
Revvity, Inc. 4.03 Billion USD 60.045%
Thermo Fisher Scientific Inc. 34.91 Billion USD 95.386%
Waters Corporation 2.35 Billion USD 31.602%